Patents by Inventor Siddhant BHOIR

Siddhant BHOIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING THE TLK1/NEK1 AXIS IN PROSTATE CANCER
    Publication number: 20240189321
    Abstract: A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.
    Type: Application
    Filed: November 15, 2023
    Publication date: June 13, 2024
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Arrigo DeBenedetti, Siddhant Bhoir, Vibha Singh, Javeena Hussain, Rupesh Chikhale, Richard Bryce, Sivapriya Kirubakaran
  • Targeting the TLK1/NEK1 axis in prostate cancer
    Patent number: 11826369
    Abstract: A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: November 28, 2023
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Arrigo DeBenedetti, Siddhant Bhoir, Vibha Singh, Javeena Hussain, Rupesh Chikhale, Richard Bryce, Sivapriya Kirubakaran
  • TARGETING THE TLK1/NEK1 AXIS IN PROSTATE CANCER
    Publication number: 20200306258
    Abstract: A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.
    Type: Application
    Filed: March 30, 2020
    Publication date: October 1, 2020
    Inventors: Arrigo DeBENEDETTI, Siddhant BHOIR, Vibha SINGH, Javeena HUSSAIN, Rupesh CHIKHALE, Richard BRYCE, Sivapriya KIRUBAKARAN